Venue: University of Copenhagen, Faculty of Pharmaceutical Sciences
Date: 07/02/2017
It will soon be possible to apply 3D-printing of medicine. Consider what it would be like to be
able to print drugs at the point of need and to utilize software apps for drug formulation
design and production.
Does this sound too futuristic? Reality is, that FDA in 2014 for the first time approved a 3Dprinted
dosage form, Spritam®. This product is manufactured using the ZipDose® platform
technology for an antiepileptic drug. The product was launched on the marked March 2016.
BUT, not only are applications within 3D-printed medicine rapidly developing, also printing
of medical applications shows huge potential for example in creating bone repair for cancer
patients.
These recent developments lead us to question, if we are at the very beginning of a new era
for the pharmaceutical industry? Please be invited to join us at this seminar, where leading
scientists will enlighten us on the use of 3D-printing within the area.
For more information see attached agenda
